Strolin Benedetti M - Search Results

1

Is the oxidation of milacemide by monoamine oxidase a major factor in its anticonvulsant actions?

O'Brien EM, Tipton KF, Strolin Benedetti M, Bonsignori A, Marrari P, Dostert P. O'Brien EM, et al. Among authors: strolin benedetti m. Biochem Pharmacol. 1991 Jun 1;41(11):1731-7. doi: 10.1016/0006-2952(91)90177-7. Biochem Pharmacol. 1991. PMID: 2043162

2

The anticonvulsant FCE 26743 is a selective and short-acting MAO-B inhibitor devoid of inducing properties towards cytochrome P450-dependent testosterone hydroxylation in mice and rats.

Strolin Benedetti MS, Marrari P, Colombo M, Castelli MG, Arand M, Oesch F, Dostert P. Strolin Benedetti MS, et al. J Pharm Pharmacol. 1994 Oct;46(10):814-9. doi: 10.1111/j.2042-7158.1994.tb03736.x. J Pharm Pharmacol. 1994. PMID: 7699569

3

Developmental aspects of the monoamine-degrading enzyme monoamine oxidase.

Strolin Benedetti M, Dostert P, Tipton KF. Strolin Benedetti M, et al. Dev Pharmacol Ther. 1992;18(3-4):191-200. Dev Pharmacol Ther. 1992. PMID: 1306808 Review.

4

Structure-modulated recognition of substrates and inhibitors by monoamine oxidases A and B.

Dostert P, Strolin Benedetti M. Dostert P, et al. Among authors: strolin benedetti m. Biochem Soc Trans. 1991 Feb;19(1):207-11. doi: 10.1042/bst0190207. Biochem Soc Trans. 1991. PMID: 2037150 Review. No abstract available.

5

MAO activity, metabolism and anticonvulsant activity of milacemide in rats and mice.

Colombo M, Strolin Benedetti M, Bonsignori A, Cocchiara G, Roncucci R, Dostert P. Colombo M, et al. Among authors: strolin benedetti m. J Neural Transm Suppl. 1990;32:123-9. doi: 10.1007/978-3-7091-9113-2_17. J Neural Transm Suppl. 1990. PMID: 2089081

6

Does FAD-dependent polyamine oxidase contribute to the metabolism of milacemide?

Strolin Benedetti M, Cocchiara G, Colombo M, Dostert P. Strolin Benedetti M, et al. J Neural Transm Suppl. 1990;32:351-6. doi: 10.1007/978-3-7091-9113-2_48. J Neural Transm Suppl. 1990. PMID: 2128509

7

Monoamine oxidase, brain ageing and degenerative diseases.

Strolin Benedetti M, Dostert P. Strolin Benedetti M, et al. Biochem Pharmacol. 1989 Feb 15;38(4):555-61. doi: 10.1016/0006-2952(89)90198-6. Biochem Pharmacol. 1989. PMID: 2521790 Review. No abstract available.

8

Interactions of monoamine oxidase with substrates and inhibitors.

Dostert PL, Strolin Benedetti M, Tipton KF. Dostert PL, et al. Among authors: strolin benedetti m. Med Res Rev. 1989 Jan-Mar;9(1):45-89. doi: 10.1002/med.2610090104. Med Res Rev. 1989. PMID: 2644497 Review. No abstract available.

9

The enzyme-activated irreversible inhibition of type-B monoamine oxidase by 3-(4-[(3-chlorophenyl)methoxy]phenyl)-5-[(methylamino) methyl]-2-oxazolidinone methanesulphonate (compound MD 780236) and the enzyme-catalysed oxidation of this compound as competing reactions.

Tipton KF, Fowler CJ, McCrodden JM, Strolin Benedetti M. Tipton KF, et al. Among authors: strolin benedetti m. Biochem J. 1983 Jan 1;209(1):235-42. doi: 10.1042/bj2090235. Biochem J. 1983. PMID: 6847610 Free PMC article.

10

Inhibition of semicarbazide-sensitive amine oxidase by monoamine oxidase B inhibitors from the oxazolidinone series.

Dostert P, Guffroy C, Strolin Benedetti M, Boucher T. Dostert P, et al. Among authors: strolin benedetti m. J Pharm Pharmacol. 1984 Nov;36(11):782-5. doi: 10.1111/j.2042-7158.1984.tb04875.x. J Pharm Pharmacol. 1984. PMID: 6150988

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters